Literature DB >> 28994757

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method.

Lilia Tierrablanca-Sánchez1, Víctor Pérez Medina Martínez1, Nancy D Ramírez Ibañez1, Néstor O Pérez Ramírez1, Francisco Luis Flores Ortiz2, Emilio Medina-Rivero3.   

Abstract

This protocol shows the measurement of the apoptotic activity neutralization of TNFα in a mouse fibroblast cell model (WEHI 164) using an anti-TNFα mAb. In addition, this protocol can be used to evaluate other anti-TNFα molecules, such as fusion proteins. The cellular model employed here is sensitive to TNFα-mediated apoptosis when an additional stress factor is induced in cell culture conditions (e.g., serum deprivation). This procedure exemplifies how to execute this analytical assay, highlighting the key operations relating to the sample preparation, cell dilution, apoptosis induction, and spectrophotometric measurements that are critical to ensure successful results. This protocol reveals the best-performance conditions relating to apoptosis induction and efficient signal recording, leading to low uncertainty values.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28994757      PMCID: PMC5752257          DOI: 10.3791/55376

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  17 in total

1.  Homogeneous time-resolved fluorescence quenching assay (LANCE) for caspase-3.

Authors:  Jarkko Karvinen; Pertti Hurskainen; Sujatha Gopalakrishnan; David Burns; Usha Warrior; Ilkka Hemmilä
Journal:  J Biomol Screen       Date:  2002-06

Review 2.  Aging and immune function: molecular mechanisms to interventions.

Authors:  Subramaniam Ponnappan; Usha Ponnappan
Journal:  Antioxid Redox Signal       Date:  2011-01-08       Impact factor: 8.401

3.  Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection.

Authors:  Dhruv Sud; Carolyn Bigbee; Joanne L Flynn; Denise E Kirschner
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

4.  Lyophilized formulations of recombinant tumor necrosis factor.

Authors:  M S Hora; R K Rana; F W Smith
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

5.  Optimal induction of tumor necrosis factor production in human monocytes requires complete S-form lipopolysaccharide.

Authors:  D N Männel; W Falk
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

6.  WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability.

Authors:  M K Eskandari; D T Nguyen; S L Kunkel; D G Remick
Journal:  Immunol Invest       Date:  1990-02       Impact factor: 3.657

Review 7.  Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection.

Authors:  Daniel E Furst; Robert Wallis; Michael Broder; David O Beenhouwer
Journal:  Semin Arthritis Rheum       Date:  2006-07-03       Impact factor: 5.532

8.  Human TNF cytokine neutralization with a vNAR from Heterodontus francisci shark: a potential therapeutic use.

Authors:  Tanya Camacho-Villegas; Teresa Mata-Gonzalez; Jorge Paniagua-Solis; Edna Sanchez; Alexei Licea
Journal:  MAbs       Date:  2012-12-05       Impact factor: 5.857

9.  Mechanisms for sensitization to TNF-induced apoptosis by acute glutathione depletion in murine hepatocytes.

Authors:  Katsuhiko Matsumaru; Cheng Ji; Neil Kaplowitz
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

10.  Trypan blue exclusion test of cell viability.

Authors:  W Strober
Journal:  Curr Protoc Immunol       Date:  2001-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.